<DOC>
	<DOCNO>NCT00383682</DOCNO>
	<brief_summary>Persistent pain occur 50-85 percent patient experience amputation extremity . This study compare effectiveness morphine mexiletine placebo treatment postamputation pain . It hypothesize effect opioids mexiletine behavior mental functioning patient postamputation pain unlikely significant barrier clinical use drug .</brief_summary>
	<brief_title>Efficacy Opioids Mexiletine Treatment Postamputation Pain</brief_title>
	<detailed_description>The long-term objective research develop well clinical strategy alleviate pain result amputation extremity . Amputation radical form nerve injury . The two major type postamputation painful sequela phantom pain stump pain . Phantom pain define painful sensation perceive miss body part , portion thereof ( Merskey Bogduk,1994 ) . Phantom pain distressing , often difficult treat , chronic neuropathic pain syndrome result direct injury peripheral central nervous system . Recent epidemiological study indicate 50-85 % patient experience persistent pain follow amputation . This control clinical trial examine role opioid analgesic local anesthetic treatment phantom associate stump pain result amputation . Specifically , objective answer follow question : 1 . Does therapy opioids mexiletine result well management postamputation pain treatment placebo ? Using randomize , blind , crossover clinical trial , effectiveness therapy opioid , morphine , oral local anesthetic , mexiletine , compare placebo management phantom associate stump pain follow amputation . The effectiveness treatment regimens judged improvement : ) The intensity ongoing , stimulus-independent pain use establish pain intensity pain relief scale , b ) Stimulus-evoked pain use quantitative sensory test , c ) Impairment function use establish measure . 2 . What relative effect opioids mexiletine affective cognitive function patient amputate extremity ? Using establish test neuropsychological function , mood , psychosocial physical impairment , affective cognitive change associate opioid mexiletine therapy quantify compare change associate placebo treatment . These study help determine effect opioids mexiletine affect cognition likely limit usefulness medication treatment pain follow amputation .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Mexiletine</mesh_term>
	<criteria>Adults ( 18 year old ) sex race persistent phantom stump pain 6 month longer follow amputation eligible enrollment study . 1 ) age le 18 85 year , 2 ) history allergic reaction study drug , i.e. , morphine mexiletine , 3 ) cardiac conduction defect second degree complete heart block , myocardial infarction last 3 month , 4 ) severe pulmonary disease , 5 ) current history alcohol substance abuse , 6 ) seizure , dementia encephalopathy , 7 ) pregnancy nurse mother , 8 ) chronic hepatic disease hepatic failure , 9 ) hematological disease associate leukopenia and/or thrombocytopenia , 10 ) terminal illness life expectancy le 6 month . 11 ) Finally , avoid bias patient selection , patient fail achieve clinically significant pain relief previous optimal trial morphine and/or mexiletine exclude . An optimal trial define minimum 3 week trial either agent use drug titration paradigm dose drug increase interval one week less .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>postamputation pain</keyword>
	<keyword>phantom pain</keyword>
	<keyword>stump pain</keyword>
	<keyword>neuroma pain</keyword>
	<keyword>opioid</keyword>
	<keyword>mexiletine</keyword>
</DOC>